References
- Coresh J, Byrd-Holt D, Astor BC, Briggs JP, et al. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol. 2005;16(1):180–188.
- Lin Z, Zhao C, Luo Q, et al. Prevalence of restless legs syndrome in chronic kidney disease: a systematic review and meta-analysis of observational studies. Ren Fail. 2016;38(9):1335–1346.
- Allen RP, Picchietti D, Hening WA, et al. Restless Legs Syndrome Diagnosis and Epidemiology workshop at the National Institutes of Health; International Restless Legs Syndrome Study Group Restless Legs Syndrome: Diagnostic Criteria, Special Considerations, and Epidemiology. A Report From the Restless Legs Syndrome Diagnosis and Epidemiology Workshop at the National Institutes of Health. Sleep Med. 2003;4:101–119.
- Allen RP, Picchietti DL, Garcia-Borreguero D, International Restless Legs Syndrome Study Group, et al . Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria-history, rationale, description, and significance . Sleep Med. 2014;15(8):860–873.
- Novak M, Mendelssohn D, Shapiro CM, et al. Diagnosis and management of sleep apnea syndrome and restless legs syndrome in dialysis patients. Semin Dial. 2006;19(3):210–216.
- Takaki J, Nishi T, Nangaku M, et al. Clinical and psychological aspects of restless legs syndrome in uremic patients on hemodialysis. Am J Kidney Dis. 2003;41(4):833–839.
- Merlino G, Lorenzut S, Gigli GL, Romano G, et al. A case-control study on restless legs syndrome in nondialyzed patients with chronic renal failure. Mov Disord. 2010;25(8):1019–1025.
- Aritake-Okada S, Nakao T, Komada Y, et al. Prevalence and clinical characteristics of restless legs syndrome in chronic kidney disease patients. Sleep Med. 2011;12(10):1031–1033.
- Calviño J, Cigarrán S, Lopez LM, et al. Restless legs syndrome in non-dialysis renal patients: is it really that common?J Clin Sleep Med. 2015;11(1):57–60.
- Trenkwalder C, Allen R, Högl B, et al . Restless legs syndrome associated with major diseases: A systematic review and new concept. Neurology. 2016;86(14):1336–1343.
- Connor JR, Ponnuru P, Wang X, Patton SM, et al. Profile of altered brain iron acquisition in restless legs syndrome. Brain. 2011;134(Pt 4):959–968.
- Laaksonen S, Voipio-Pulkki L, Erkinjuntti M, et al. Does dialysis therapy improve autonomic and peripheral nervous system abnormalities in chronic uraemia?J Intern Med. 2000;248(1):21–26.
- Pop-Busui R, Roberts L, Pennathur S, et al. The management of diabetic neuropathy in CKD. Am J Kidney Dis. 2010;55(2):365–385.
- Hoque R, Chesson AL.Jr. Pharmacologically induced/exacerbated restless legs syndrome, periodic limb movements of sleep, and REM behavior disorder/REM sleep without atonia: literature review, qualitative scoring, and comparative analysis. J Clin Sleep Med. 2010;06(01):79–83.
- Molnar MZ, Novak M, Ambrus C, et al. Restless Legs Syndrome in patients after renal transplantation. Am J Kidney Dis. 2005;45(2):388–396.
- Gade K, Blaschke S, Rodenbeck A, et al. Uremic restless legs syndrome (RLS) and sleep quality in patients with end-stage renal disease on hemodialysis: potential role of homocysteine and parathyroid hormone. Kidney Blood Press Res. 2013;37(4-5):458–463.
- Santos RS, Coelho FM, da Silva BC, et al. parathyroidectomy improves restless leg syndrome in patients on hemodialysis. PLoS One. 2016;11(5):e0155835.
- Urabe S, Hosono T, Hyodo T, et al. Restless legs syndrome effectively treated with constant-pressure predilution online hemodiafiltration. J Artif Organs. 2019;22(3):253–255.
- Cirignotta F, Mondini S, Santoro A, et al. Reliability of a questionnaire screening restless legs syndrome in patients on chronic dialysis. Am J Kidney Dis. 2002;40(2):302–306.
- Gigli GL, Adorati M, Dolso P, et al. Restless legs syndrome in end-stage renal disease. Sleep Med. 2004;5(3):309–315.
- Kim JM, Kwon HM, Lim CS, et al. Restless legs syndrome in patients on hemodialysis: symptom severity and risk factors. J Clin Neurol. 2008;4(4):153–157.
- Sabry AA, Abo-Zenah H, Wafa E, et al. Sleep disorders in hemodialysis patients. Saudi J Kidney Dis Transpl. 2010;21:300–305.
- Ibrahim JM, Wegdan OM. Epidemiology of sleep disorders in patients with chronic renal disease in Cairo, Egypt. J Egypt Public Health Assoc. 2011;86(3-4):68–72.
- Miranda M, Araya F, Castillo JL, et al. Restless legs syndrome: a clinical study in adult general population and in uremic patients. Rev Med Chil. 2001;129:179–186.
- Janzen L, Rich JA, Vercaigne LM. An overview of levodopa in the management of restless legs syndrome in a dialysis population: pharmacokinetics, clinical trials, and complications of therapy. Ann Pharmacother. 1999;33(1):86–92.
- Owen WF, Lew NL, Liu Y, et al. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med. 1993;329(14):1001–1006.
- Abdel-Tawab AA. Parameters for social classification for health research. Arabic examiner’s handbook. Cairo: Dar El-Anglo, 2010.
- Shalash AS, Elrassas HH, Mahmoud M, Monzem MM, et al. Restless legs syndrome in egyptian medical students using a validated Arabic version of the restless legs syndrome rating scale. Sleep Med. 2015;16(12):1528–1531.
- Walters AS, LeBrocq C, Dhar A, et al. Validation of the international restless legs syndrome study group rating scale for restless legs syndrome. Sleep Med. 2003;4:121–132.
- Johns MW. A new method for measuring daytime sleepiness: The Epworth Sleepiness Scale. Sleep. 1991;14(6):540–545.
- Ahmed AE, Fatani A, Al-Harbi A, et al. Validation of the Arabic version of the Epworth sleepiness scale. JEGH. 2014;4(4):297–302.
- Morin CM, Belleville G, Bélanger L, et al. The Insomnia severity index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep. 2011;34(5):601–608.
- Suleiman KH, Yates BC, Berger AM, et al. Translating the insomnia severity index into Arabic. West J Nurs Res. 2010;32(2):250–268.
- Beck AT, Steer RA, Ball R, et al. Comparison of beck depression inventories -IA and -II in psychiatric outpatients. J Pers Assess. 1996;67(3):588–597.
- Gharyb AG. Beck Depression Inventory II (BDI-II): Arabic examiner’s handbook. Cairo: Dar El-Anglo; 2000.
- El-Beheary AA. The state-trait anxiety inventory. Arabic examiner’s handbook. Cairo: Dar El-Anglo; 2007.
- Spielberger CD, Gorsuch RL, Lushene R, et al. Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press; 1983.
- Garcic A. A highly sensitive, simple determination of serum iron using chromazurol B. Clin Chim Acta. 1979;94(2):115–119.
- Salman SM. Restless legs syndrome in patients on hemodialysis. Saudi J Kidney Dis Transpl. 2011;22(2):368–372.
- Araujo SM, de Bruin VM, Nepomuceno LA, et al. Restless legs syndrome in end-stage renal disease: clinical characteristics and associated comorbidities. Sleep Med. 2010;11(8):785–790.
- Collado-Seidel V, Kohnen R, Samtleben W, Hillebrand GF, et al. Clinical and biochemical findings in uremic patients with and without restless legs syndrome. Am J Kidney Dis. 1998;31(2):324–328.
- Lin CH, Wu VC, Li WY, Sy HN, et al. Restless legs syndrome is associated with cardio/cerebrovascular events and mortality in end-stage renal disease. Eur J Neurol. 2013;20(7):1025–1031.
- Lee J, Nicholl DDM, Ahmed SB, et al. The prevalence of restless legs syndrome across the full spectrum of kidney disease. J Clin Sleep Med. 2013;09(05):455–459.
- Stefanidis I, Vainas A, Dardiotis E, et al. Restless legs syndrome in hemodialysis patients: an epidemiologic survey in Greece. Sleep Med. 2013;14(12):1381–1386.
- Mizuno S, Miyaoka T, Inagaki T, et al. Prevalence of restless legs syndrome in non-institutionalized Japanese elderly. Psychiatry Clin Neurosci. 2005;59(4):461–465.
- Chen J, Wildman RP, Gu D, Kusek JW, et al. Prevalence of decreased kidney function in Chinese adults aged 35 to 74 years. Kidney Int. 2005;68(6):2837–2845.
- Bayard M, Avonda T, Wadzinski J. Restless legs syndrome. Am Fam Physician. 2008;78(2):235–240.
- Giannaki CD, Hadjigeorgiou GM, Karatzaferi C, et al. Epidemiology, impact, and treatment options of restless legs syndrome in end-stage renal disease patients: an evidence-based review. Kidney Int. 2014;85(6):1275–1282.
- Krishnan AV, Kiernan MC. Uremic neuropathy: clinical features and new pathophysiological insights. Muscle Nerve. 2007;35(3):273–290.
- Scarpioni S, Ricardi M, Albertazzi V, et al. Dialysis-related amyloidosis: challenges and solutions. Int J Nephrol Renovasc Dis. 2016;9:319–328.
- Sloand JA, Shelly MA, Feigin A, et al . A double-blind, placebo-controlled trial of intravenous iron dextran therapy in patients with ESRD and restless legs syndrome. Am J Kidney Dis. 2004; Apr43(4):663–670. PMID: 15042543
- Connor JR, Patton SM, Oexle K, Richard P Allen RP. Iron and restless legs syndrome: treatment, genetics and pathophysiology. Sleep Med. 2017;31:61–70.
- Wali SO, Alkhouli AF. Restless legs syndrome among Saudi end-stage renal disease patients on hemodialysis. Saudi Med J. 2015;36(2):204–210.
- Earley CJ, Connor JR, Beard JL, et al. Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome. Neurology. 2000;54(8):1698–1700.
- Mills E, Dong X, Wang F, et al. Mechanisms of brain iron transport: insight into neurodegeneration and CNS disorders. Future Med Chem. 2010;2(1):51–64.
- O’Keeffe ST, Gavin K, Lavan JN. Iron status and restless legs syndrome in the elderly. Age Ageing. 1994;23(3):200–203.
- Gamaldo C, Salas RE, Collop NA. Complex arrhythmia during a sleep study–what to do?J Clin Sleep Med. 2009;05(02):171–173.
- Soreide E, Kirvelä O, Lynn R, et al. Branched-chain amino acid in chronic renal failure patients: respiratory and sleep effects. Kidney Int. 1991;40(3):539–543.
- Vaziri ND, Oveisi F, Wierszbiezki M, et al . Serum melatonin and 6-sulfatoxymelatonin in end-stage renal disease: effect of hemodialysis. Artif Organs. 1993;17(9):764–769.
- Entzian P, Linnemann K, Schlaak M, et al. Obstructive sleep apnea syndrome and circadian rhythms of hormones and cytokines. Am J Respir Crit Care Med. 1996;153(3):1080–1086.